Six major HCV genotypes (HCV1–6) have been identified, which vary in their geographic distribution and response to treatments. Figure 1: Worldwide prevalence of hepatitis C in millions.

A rich R&D pipeline of second-wave DAAs could build on that achievement, with even more impressive efficacy, shorter treatment durations and better coverage of all hepatitis C genotypes.

The FDA approved Vosevi (sofosbuvir+velpatasvir+voxilepravir), offering a single-tablet regimen for retreatment of adults with any of the six major hepatitis C genotypes who have previously ...

Before starting treatment, you need to take a simple blood test to learn which genotype you have. Some DAAs can be used to treat all hepatitis C genotypes. Effective direct-acting antiviral or 'DAA' ...

Hepatitis C is the most common and is typically chronic ... Prior research has shown that the hepatitis E virus has eight genotypes; only types one and two have been detected in human patients ...

HBV DNA Double-stranded hepatitis B DNA. The presence of HBV ... (i.e., 24 weeks for genotype 2 and 3 and 48 weeks for other genotypes) Relapse – Defined as undetectable plasma HCV RNA at ...

The Hepatitis C virus (HCV) is one of the most common forms of viral hepatitis in the UK. It can cause liver scarring (cirrhosis), liver cancer and failure of the liver. The virus has evolved into ...